DALLAS, July 30, 2009 (GLOBE NEWSWIRE) -- Kendall Law Group (www.kendalllawgroup.com) is investigating shareholder claims into the sale of Medarex (Nasdaq:MEDX) to Bristol-Myers Squibb. The law firm is investigating the sale because the tender offer price is well below the company's peak historical share price and appears to be timed to take advantage of the global economic downturn.
For information about your rights as a Medarex shareholder, contact attorney Hamilton Lindley at 877-744-3728 or by email at hlindley@kendalllawgroup.com. Kendall Law Group is led by a former federal judge and U.S. Attorney. The firm has nationwide experience representing investors in mergers and acquisitions.
The Kendall Law Group, LLP logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6273